Hydrogen Gas Inhalation Attenuates Endothelial Glycocalyx Damage and Stabilizes Hemodynamics in a Rat Hemorrhagic Shock Model.
Tamura T, Sano M, Matsuoka T, Yoshizawa J, Yamamoto R, Katsumata Y, Endo J, Homma K, Kajimura M, Suzuki M, Kobayashi E, Sasaki J · Shock (Augusta, Ga.) · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, H₂ and XOR-I both suppressed MAP reduction and improved survival rates. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.
What the Researchers Studied
The study examined rats.
How Molecular Hydrogen Was Used
Rats inhaled oxygen or H₂ + oxygen after achieving shock either in the presence or absence of an XOR inhibitor (XOR-I) for both the groups.
What the Researchers Found
H₂ and XOR-I both suppressed MAP reduction and improved survival rates. H₂ inhalation after shock stabilized hemodynamics and improved survival rates in an HS/R model independent of XOR.
H₂ Mechanisms / Biological Findings
The source material reviewed did not establish a specific molecular hydrogen mechanism for the reported findings.
Authors’ Conclusion
The authors concluded that H₂ inhalation after shock stabilized hemodynamics and improved survival rates in an HS/R model independent of XOR.